首页 > 最新文献

International Journal of Vascular Medicine最新文献

英文 中文
The Long-Term Progression of Aneurysmal Disease in Common Iliac Arteries After Standard EVAR and Its Clinical Implications.
IF 2.5 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-11-29 eCollection Date: 2024-01-01 DOI: 10.1155/ijvm/4229582
Apostolos G Pitoulias, Dimitrios Chatzelas, Matthaios G Pitoulias, Loukia A Politi, Dimitrios C Christopoulos, Ioannis Lazaridis, Nikolaos Saratzis, Georgios A Pitoulias

Introduction: The progression of aneurysmal disease in the common iliac arteries (CIAs) after EVAR remains an insufficiently investigated field. The purpose of this study is to investigate the long-term outcomes of standard elective EVAR with a variety of last-generation bifurcated aortic endografts in relation with the progression of aneurysmal disease in the CIAs. Methods: This is a prospective cohort study of 168 patients, who were treated with six different endografts between 2013 and 2018 and completed the 5-year computed tomography aortoangiography (CTA) follow-up. Postoperative CTA analysis included CIA measurements at four diameters' points and two length levels in three postoperative time spots: first, 24th, and 60th months. All EVAR-related adverse events were recorded, including migrations, endoleaks, limb occlusions, reinterventions, ruptures, and mortality. Results: At both time intervals, a significant and nearly linear dilatation and elongation of CIAs was evident. The mean percent increase, among all diameter points measured, was 11.7% at 24 months and 22.8% at 60 months (p < 0.001) with a nearly constant mean increase rate by 0.07 mm per month. The corresponding monthly elongation rate of total CIA length was 0.26 mm at 24 months and 0.34 mm at 5 years (p < 0.001). The respective monthly lengthening of CIAs' uncovered (from stent graft) segment was 0.10 and 0.15 mm, and the overall increase rate at 60 months was up to 53.9% (p < 0.001). A total of 20 EVAR-related events were recorded, and multivariate analysis revealed that CIA dilatation served as a significant and independent predictor of long-term EVAR failures, increasing the likelihood of adverse events by 2.8-fold. Conclusions: Analysis of long-term geometric CIA remodeling after a standard EVAR revealed a significant progression of aneurysmal disease in CIAs, which was associated with worsening EVAR outcomes and emphasizes the importance of a rigorous and extensive follow-up protocol to maintain the long-term EVAR effectiveness.

{"title":"The Long-Term Progression of Aneurysmal Disease in Common Iliac Arteries After Standard EVAR and Its Clinical Implications.","authors":"Apostolos G Pitoulias, Dimitrios Chatzelas, Matthaios G Pitoulias, Loukia A Politi, Dimitrios C Christopoulos, Ioannis Lazaridis, Nikolaos Saratzis, Georgios A Pitoulias","doi":"10.1155/ijvm/4229582","DOIUrl":"10.1155/ijvm/4229582","url":null,"abstract":"<p><p><b>Introduction:</b> The progression of aneurysmal disease in the common iliac arteries (CIAs) after EVAR remains an insufficiently investigated field. The purpose of this study is to investigate the long-term outcomes of standard elective EVAR with a variety of last-generation bifurcated aortic endografts in relation with the progression of aneurysmal disease in the CIAs. <b>Methods:</b> This is a prospective cohort study of 168 patients, who were treated with six different endografts between 2013 and 2018 and completed the 5-year computed tomography aortoangiography (CTA) follow-up. Postoperative CTA analysis included CIA measurements at four diameters' points and two length levels in three postoperative time spots: first, 24th, and 60th months. All EVAR-related adverse events were recorded, including migrations, endoleaks, limb occlusions, reinterventions, ruptures, and mortality. <b>Results:</b> At both time intervals, a significant and nearly linear dilatation and elongation of CIAs was evident. The mean percent increase, among all diameter points measured, was 11.7% at 24 months and 22.8% at 60 months (<i>p</i> < 0.001) with a nearly constant mean increase rate by 0.07 mm per month. The corresponding monthly elongation rate of total CIA length was 0.26 mm at 24 months and 0.34 mm at 5 years (<i>p</i> < 0.001). The respective monthly lengthening of CIAs' uncovered (from stent graft) segment was 0.10 and 0.15 mm, and the overall increase rate at 60 months was up to 53.9% (<i>p</i> < 0.001). A total of 20 EVAR-related events were recorded, and multivariate analysis revealed that CIA dilatation served as a significant and independent predictor of long-term EVAR failures, increasing the likelihood of adverse events by 2.8-fold. <b>Conclusions:</b> Analysis of long-term geometric CIA remodeling after a standard EVAR revealed a significant progression of aneurysmal disease in CIAs, which was associated with worsening EVAR outcomes and emphasizes the importance of a rigorous and extensive follow-up protocol to maintain the long-term EVAR effectiveness.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2024 ","pages":"4229582"},"PeriodicalIF":2.5,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623987/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142800685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Brachial Compression Versus Ulnar Compression on Radial Artery Diameter: A Randomized Controlled Trial. 肱动脉压迫与尺动脉压迫对桡动脉直径的影响比较:随机对照试验
IF 2.5 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-11-14 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9965794
Fatemeh Bahrami, Shayan Mirshafiee, Pejman Mansouri, Mohammadreza Eftekhari, Mohammad Vahidi, Fateme Baharvand, Ehsan Moradi Farsani, Hamed Vahidi

Objectives: This study is aimed at comparing the effectiveness of ulnar compression and brachial compression in inducing radial artery dilatation. Methods: This randomized crossover study included 30 patients undergoing elective diagnostic transradial coronary angiography. Ulnar compression and brachial compression maneuvers were performed in two groups. Radial artery diameter and cross-sectional area were measured at baseline and remeasured every 30 s (up to 2 min) after the interventions. Results: Both ulnar compression and brachial compression maneuvers successfully increased radial artery diameter for up to 60 s following the interventions. There were no statistically significant differences between the two groups after adjusting for baseline measurements. However, each treatment group showed a significant increase in indicators up to 60 s, followed by a subsequent decrease. The maximum radial artery diameter occurred at 60 s after the removal of compression in both groups. Conclusion: Ulnar compression and brachial compression maneuvers demonstrated effectiveness in inducing radial artery dilation for a limited duration. These maneuvers may reduce the occurrence of access failure during radial artery cannulation. No significant differences were observed between the two maneuvers, indicating that they can be used interchangeably based on clinician preference. So, because the ulnar compression is simpler and more feasible for the patients, it can be considered instead of brachial compression. Trial Registration: IRCT20230209057372N1.

研究目的本研究旨在比较尺骨压迫和肱骨压迫在诱导桡动脉扩张方面的效果。方法:随机交叉研究:这项随机交叉研究包括 30 名接受择期经桡动脉冠状动脉造影诊断的患者。两组患者分别进行了尺动脉压迫和肱动脉压迫操作。基线时测量桡动脉直径和横截面积,干预后每隔 30 秒(最长 2 分钟)重新测量一次。结果:尺骨压迫和肱动脉压迫均能在干预后 60 秒内成功增加桡动脉直径。在调整基线测量值后,两组之间没有明显的统计学差异。不过,每个治疗组的指标在 60 秒内都有显著增加,随后又有所减少。两组的最大桡动脉直径都出现在解除压迫后的 60 秒。结论尺骨压迫和肱骨压迫手法在诱导桡动脉扩张方面具有一定的有效性。这些方法可减少桡动脉插管过程中出现的通路失败。两种手法之间没有明显差异,这表明它们可以根据临床医生的偏好交替使用。因此,由于尺动脉压迫对患者来说更简单可行,可以考虑用它来代替肱动脉压迫。试验注册:IRCT20230209057372N1.
{"title":"Comparison of Brachial Compression Versus Ulnar Compression on Radial Artery Diameter: A Randomized Controlled Trial.","authors":"Fatemeh Bahrami, Shayan Mirshafiee, Pejman Mansouri, Mohammadreza Eftekhari, Mohammad Vahidi, Fateme Baharvand, Ehsan Moradi Farsani, Hamed Vahidi","doi":"10.1155/2024/9965794","DOIUrl":"10.1155/2024/9965794","url":null,"abstract":"<p><p><b>Objectives:</b> This study is aimed at comparing the effectiveness of ulnar compression and brachial compression in inducing radial artery dilatation. <b>Methods:</b> This randomized crossover study included 30 patients undergoing elective diagnostic transradial coronary angiography. Ulnar compression and brachial compression maneuvers were performed in two groups. Radial artery diameter and cross-sectional area were measured at baseline and remeasured every 30 s (up to 2 min) after the interventions. <b>Results:</b> Both ulnar compression and brachial compression maneuvers successfully increased radial artery diameter for up to 60 s following the interventions. There were no statistically significant differences between the two groups after adjusting for baseline measurements. However, each treatment group showed a significant increase in indicators up to 60 s, followed by a subsequent decrease. The maximum radial artery diameter occurred at 60 s after the removal of compression in both groups. <b>Conclusion:</b> Ulnar compression and brachial compression maneuvers demonstrated effectiveness in inducing radial artery dilation for a limited duration. These maneuvers may reduce the occurrence of access failure during radial artery cannulation. No significant differences were observed between the two maneuvers, indicating that they can be used interchangeably based on clinician preference. So, because the ulnar compression is simpler and more feasible for the patients, it can be considered instead of brachial compression. <b>Trial Registration:</b> IRCT20230209057372N1.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2024 ","pages":"9965794"},"PeriodicalIF":2.5,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analyzing Cardiovascular Disease Research in the Arab Region: A Bibliometric Review From 2012 to 2022. 分析阿拉伯地区的心血管疾病研究:2012 年至 2022 年文献计量学回顾》。
IF 2.5 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-12 eCollection Date: 2024-01-01 DOI: 10.1155/2024/5915132
Amjad Bani Hani, Alaa Tarazi, Yazan Hamadneh, Ahmad Al-Samahan, Rami Awad, Mohammad Kan'an, Mohammad Al-Kasaji, Nidal A Younes

Background: Cardiovascular diseases (CVDs) remain the leading cause of mortality, especially in low- and middle-income countries, many of which are in the Arab region. We aimed to conduct a bibliometric analysis to assess the scientific output concerning CVDs in the Arab region and the Middle East over the past decade. Methods: A bibliometric search was conducted on PubMed and Scopus between 2012 and 2022. The study analyzed the number of publications, countries, institutional sources, authors, journals, and keywords. Visualization analysis was executed using various software tools, including R, VOSviewer, and CiteSpace. Results: PubMed and Scopus yielded 5340 documents related to CVDs at the time of data collection. A total of 1263 documents were retrieved after screening based on specific inclusion criteria that guarantee the inclusion only for Arab region studies and authors. There has been a consistent increase in annual publications in recent years. The countries that contributed the most to research in this field were Egypt, Saudi Arabia, and the UAE. Although Egypt stood out as the most productive country, the institute with the highest number of documents was in Qatar. In addition, the Top 3 authors hailed from Qatar. Saudi Medical Journal leads the field as the most productive journal, followed closely by PLoS One and Angiology. Research topics of significant interest in the realm of CVDs include specific diseases such as heart failure, risk factors related to CVDs, genetic aspects of CVDs, and congenital disorders in infant's cardiac health. Conclusion: This study provides a comprehensive overview of the current status of CVD research in the Arab region. It includes research hotspots that can guide authors in determining the necessary future investigations within this field. There is a clear call for further exploration of various aspects of CVDs in the Arab world. Strengthening cooperation between countries and institutes is needed.

背景:心血管疾病(CVDs)仍然是导致死亡的主要原因,尤其是在中低收入国家,其中许多国家位于阿拉伯地区。我们旨在进行文献计量分析,以评估过去十年阿拉伯地区和中东有关心血管疾病的科学成果。方法:我们在 PubMed 和 Scopus 上进行了文献计量学检索,检索时间为 2012 年至 2022 年。研究分析了出版物的数量、国家、机构来源、作者、期刊和关键词。使用各种软件工具(包括 R、VOSviewer 和 CiteSpace)进行了可视化分析。结果在收集数据时,PubMed 和 Scopus 共收录了 5340 篇与心血管疾病相关的文献。根据特定的纳入标准(保证只纳入阿拉伯地区的研究和作者)进行筛选后,共检索到 1263 篇文献。近年来,每年发表的论文数量持续增长。对该领域研究贡献最大的国家是埃及、沙特阿拉伯和阿联酋。虽然埃及是成果最多的国家,但文献数量最多的机构却是卡塔尔。此外,前三名作者均来自卡塔尔。沙特医学杂志》是该领域产量最高的期刊,《PLoS One》和《血管病学》紧随其后。心血管疾病领域的重要研究课题包括心力衰竭等特定疾病、与心血管疾病相关的风险因素、心血管疾病的遗传因素以及婴儿心脏健康的先天性疾病。结论本研究全面概述了阿拉伯地区心血管疾病的研究现状。它包括一些研究热点,可指导作者确定该领域未来必要的调查。显然,阿拉伯世界需要进一步探索气相化学变化的各个方面。需要加强国家和机构之间的合作。
{"title":"Analyzing Cardiovascular Disease Research in the Arab Region: A Bibliometric Review From 2012 to 2022.","authors":"Amjad Bani Hani, Alaa Tarazi, Yazan Hamadneh, Ahmad Al-Samahan, Rami Awad, Mohammad Kan'an, Mohammad Al-Kasaji, Nidal A Younes","doi":"10.1155/2024/5915132","DOIUrl":"10.1155/2024/5915132","url":null,"abstract":"<p><p><b>Background:</b> Cardiovascular diseases (CVDs) remain the leading cause of mortality, especially in low- and middle-income countries, many of which are in the Arab region. We aimed to conduct a bibliometric analysis to assess the scientific output concerning CVDs in the Arab region and the Middle East over the past decade. <b>Methods:</b> A bibliometric search was conducted on PubMed and Scopus between 2012 and 2022. The study analyzed the number of publications, countries, institutional sources, authors, journals, and keywords. Visualization analysis was executed using various software tools, including R, VOSviewer, and CiteSpace. <b>Results:</b> PubMed and Scopus yielded 5340 documents related to CVDs at the time of data collection. A total of 1263 documents were retrieved after screening based on specific inclusion criteria that guarantee the inclusion only for Arab region studies and authors. There has been a consistent increase in annual publications in recent years. The countries that contributed the most to research in this field were Egypt, Saudi Arabia, and the UAE. Although Egypt stood out as the most productive country, the institute with the highest number of documents was in Qatar. In addition, the Top 3 authors hailed from Qatar. Saudi Medical Journal leads the field as the most productive journal, followed closely by PLoS One and Angiology. Research topics of significant interest in the realm of CVDs include specific diseases such as heart failure, risk factors related to CVDs, genetic aspects of CVDs, and congenital disorders in infant's cardiac health. <b>Conclusion:</b> This study provides a comprehensive overview of the current status of CVD research in the Arab region. It includes research hotspots that can guide authors in determining the necessary future investigations within this field. There is a clear call for further exploration of various aspects of CVDs in the Arab world. Strengthening cooperation between countries and institutes is needed.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2024 ","pages":"5915132"},"PeriodicalIF":2.5,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490352/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Clinical and Imaging Findings in Patients with Lower Extremity Varicose Veins Treated with Endovenous Laser Treatment: A Follow-Up Study of up to 12 Years. 静脉腔内激光治疗下肢静脉曲张患者的长期临床和成像结果:长达 12 年的随访研究。
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-02-06 eCollection Date: 2024-01-01 DOI: 10.1155/2024/6829868
Hossein Ghanaati, Amir Hossein Jalali, Madjid Shakiba, Diana Zarei, Nafiseh Ghavami, Kavous Firouznia

Introduction: This study investigates the long-term effectiveness and safety of endovenous laser treatment (EVLT) for chronic venous insufficiency (CVI), a condition commonly caused by dysfunctional valves in the venous circulation system.

Materials and methods: In this retrospective cohort study, patients underwent EVLT and were followed up for successive short intervals and one last time after a median duration of 9-year postprocedural. Pre- and postprocedure duplex ultrasound was used to assess changes in the great saphenous vein (GSV) diameter, reflux, and saphenofemoral junction incompetence. Quality of life was evaluated using the SF-36 and Aberdeen Varicose Vein Questionnaire (AVVQ).

Results: Sixty-eight patients with a mean age of 52.4 ± 12.4 years were enrolled in the study. The mean follow-up time was 8.9 ± 2.1 years, ranging from 5 to 12 years. The mean GSV diameter significantly decreased in all patients (whole group) across proximal (from 5.8 ± 2.3 mm to 4.2 ± 2.1 mm), middle (from 4.7 ± 1.6 mm to 2.8 ± 2.2 mm), and distal (from 4.5 ± 2.3 mm to 2.2 ± 2.2 mm) segments, with P < 0.001. A disease recurrence rate of 33.8% was noted, predominantly in male patients and those with larger middle GSV diameters (OR = 5.2 (95%CI = 1.3-20.4) and OR = 1.5 (95%CI = 1-2.1), respectively). The average follow-up time for patients without recurrence was 8.8 ± 2.1 years. Almost half of the patients without recurrence were followed up for 10 years or more (49%).

Conclusion: The efficacy of EVLT in managing varicose veins is demonstrated by its relatively low recurrence rate over a 10-year follow-up period, highlighting EVLT as a viable long-term treatment strategy.

简介:慢性静脉功能不全(CVI)是由静脉循环系统中的瓣膜功能失调引起的一种常见疾病,本研究调查了静脉腔内激光治疗(EVLT)的长期有效性和安全性:在这项回顾性队列研究中,患者接受了 EVLT 治疗,并在术后接受了连续的短期随访和最后一次随访,中位随访时间为术后 9 年。术前和术后双工超声用于评估大隐静脉(GSV)直径、回流和隐股交界处闭锁的变化。使用 SF-36 和阿伯丁静脉曲张问卷(AVVQ)评估生活质量:研究共纳入 68 名患者,平均年龄为(52.4 ± 12.4)岁。平均随访时间为 8.9 ± 2.1 年,从 5 年到 12 年不等。所有患者(全组)的近段(从 5.8 ± 2.3 mm 到 4.2 ± 2.1 mm)、中段(从 4.7 ± 1.6 mm 到 2.8 ± 2.2 mm)和远段(从 4.5 ± 2.3 mm 到 2.2 ± 2.2 mm)的平均 GSV 直径均明显缩小,P < 0.001。疾病复发率为 33.8%,主要发生在男性患者和 GSV 中段直径较大的患者中(OR = 5.2 (95%CI = 1.3-20.4) 和 OR = 1.5 (95%CI = 1-2.1))。未复发患者的平均随访时间为 8.8 ± 2.1 年。近一半未复发的患者接受了 10 年或更长时间的随访(49%):结论:EVLT治疗静脉曲张的疗效体现在其10年随访期间相对较低的复发率上,突出表明EVLT是一种可行的长期治疗策略。
{"title":"Long-Term Clinical and Imaging Findings in Patients with Lower Extremity Varicose Veins Treated with Endovenous Laser Treatment: A Follow-Up Study of up to 12 Years.","authors":"Hossein Ghanaati, Amir Hossein Jalali, Madjid Shakiba, Diana Zarei, Nafiseh Ghavami, Kavous Firouznia","doi":"10.1155/2024/6829868","DOIUrl":"10.1155/2024/6829868","url":null,"abstract":"<p><strong>Introduction: </strong>This study investigates the long-term effectiveness and safety of endovenous laser treatment (EVLT) for chronic venous insufficiency (CVI), a condition commonly caused by dysfunctional valves in the venous circulation system.</p><p><strong>Materials and methods: </strong>In this retrospective cohort study, patients underwent EVLT and were followed up for successive short intervals and one last time after a median duration of 9-year postprocedural. Pre- and postprocedure duplex ultrasound was used to assess changes in the great saphenous vein (GSV) diameter, reflux, and saphenofemoral junction incompetence. Quality of life was evaluated using the SF-36 and Aberdeen Varicose Vein Questionnaire (AVVQ).</p><p><strong>Results: </strong>Sixty-eight patients with a mean age of 52.4 ± 12.4 years were enrolled in the study. The mean follow-up time was 8.9 ± 2.1 years, ranging from 5 to 12 years. The mean GSV diameter significantly decreased in all patients (whole group) across proximal (from 5.8 ± 2.3 mm to 4.2 ± 2.1 mm), middle (from 4.7 ± 1.6 mm to 2.8 ± 2.2 mm), and distal (from 4.5 ± 2.3 mm to 2.2 ± 2.2 mm) segments, with <i>P</i> < 0.001. A disease recurrence rate of 33.8% was noted, predominantly in male patients and those with larger middle GSV diameters (OR = 5.2 (95%CI = 1.3-20.4) and OR = 1.5 (95%CI = 1-2.1), respectively). The average follow-up time for patients without recurrence was 8.8 ± 2.1 years. Almost half of the patients without recurrence were followed up for 10 years or more (49%).</p><p><strong>Conclusion: </strong>The efficacy of EVLT in managing varicose veins is demonstrated by its relatively low recurrence rate over a 10-year follow-up period, highlighting EVLT as a viable long-term treatment strategy.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2024 ","pages":"6829868"},"PeriodicalIF":1.3,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10864052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139735140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiopoietin-2 Is Associated with Aortic Stiffness in Diabetes Patients in Ghana: A Case-Control Study. 加纳糖尿病患者血管生成素-2与主动脉硬化相关:一项病例对照研究。
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-10-12 eCollection Date: 2023-01-01 DOI: 10.1155/2023/3155982
Jennifer A Agyekum, Kwame Yeboah

Objective: Impaired angiogenesis, measured as serum levels of angiogenic growth factors, may be among the mechanisms underlining aortic stiffness in diabetes patients. We studied the association between aortic stiffness and circulating angiogenic growth factors in type 2 diabetes (T2DM) patients without any organ damage.

Methods: In a case-control design, aortic pulse wave velocity (PWV), augmentation index (AIx), and aortic blood pressures (BPs) were measured in 140 T2DM patients and 110 nondiabetic controls. Fasting blood samples were collected to measure the levels of angiopoietin- (Ang-) 1, Ang-2, and vascular endothelial growth factor-A (VEGF).

Results: Compared to nondiabetes participants, T2DM patients had increased PWV (8.7 ± 1.5 vs. 7.6 ± 1.3, p = 0.031), aortic pulse BP (58 ± 20 vs. 49 ± 17, p = 0.011), Ang-2 (838 (473-1241) vs. 597 (274-1005), p = 0.018), and VEGF (72.2 (28-201.8) vs. 48.4 (17.4-110.1), p = 0.025) but reduced levels of AIx (21.7 ± 13.8 vs. 34 ± 12.9, p < 0.001) and Ang-1 (33.1 (24.7-42.1) vs. 41.1 (30-57.3), p = 0.01). In all study participants, compared to those in the lower tertile, participants in the upper tertile of Ang-2 had increased odds of PWV (2.01 (1.17-3.84), p = 0.004), aortic systolic BP (1.24 (1.04-1.97), p = 0.011), and aortic pulse BP (1.19 (1.04-1.82), p = 0.041) but reduced odds of AIx (0.84 (0.71-0.96), p = 0.014) in multivariable-adjusted models.

Conclusion: In our study population, increased circulating Ang-2 was associated with increased levels of aortic stiffness parameters.

目的:血管生成受损,以血管生成生长因子的血清水平衡量,可能是糖尿病患者主动脉硬化的机制之一。我们研究了在没有任何器官损伤的2型糖尿病(T2DM)患者中主动脉硬化与循环血管生成生长因子之间的关系。方法:在病例对照设计中,测量140名T2DM患者和110名非糖尿病对照的主动脉脉搏波速度(PWV)、增宽指数(AIx)和主动脉血压(BP)。采集空腹血样以测量血管生成素-(Ang-)1、Ang-2和血管内皮生长因子-A(VEGF)的水平。结果:与非糖尿病参与者相比,T2DM患者的PWV(8.7±1.5 vs.7.6±1.3,p=0.031)、主动脉脉压(58±20 vs.49±17,p=0.011)、Ang-2(838(473-1241)vs.597(274-1005),p=0.018)增加,和VEGF(72.2(28-201.8)vs.48.4(17.4-110.1),p=0.025),但AIx水平降低(21.7±13.8 vs.34±12.9,p<0.001)和Ang-1水平降低(33.1(24.7-42.1)vs.41.1(30-57.3),p=0.01)。在所有研究参与者中,与下三分位数的参与者相比,Ang-2上三分位数参与者的PWV(2.01(1.17-3.84),p=0.004)、主动脉收缩压(1.24(1.04-1.97),p=0.011)和主动脉脉搏BP(1.19(1.04-1.82),p=0.041),但在多变量调整模型中AIx的几率降低(0.84(0.71-0.96),p=0.014)。结论:在我们的研究人群中,循环Ang-2的增加与主动脉硬化参数水平的增加有关。
{"title":"Angiopoietin-2 Is Associated with Aortic Stiffness in Diabetes Patients in Ghana: A Case-Control Study.","authors":"Jennifer A Agyekum,&nbsp;Kwame Yeboah","doi":"10.1155/2023/3155982","DOIUrl":"10.1155/2023/3155982","url":null,"abstract":"<p><strong>Objective: </strong>Impaired angiogenesis, measured as serum levels of angiogenic growth factors, may be among the mechanisms underlining aortic stiffness in diabetes patients. We studied the association between aortic stiffness and circulating angiogenic growth factors in type 2 diabetes (T2DM) patients without any organ damage.</p><p><strong>Methods: </strong>In a case-control design, aortic pulse wave velocity (PWV), augmentation index (AIx), and aortic blood pressures (BPs) were measured in 140 T2DM patients and 110 nondiabetic controls. Fasting blood samples were collected to measure the levels of angiopoietin- (Ang-) 1, Ang-2, and vascular endothelial growth factor-A (VEGF).</p><p><strong>Results: </strong>Compared to nondiabetes participants, T2DM patients had increased PWV (8.7 ± 1.5 vs. 7.6 ± 1.3, <i>p</i> = 0.031), aortic pulse BP (58 ± 20 vs. 49 ± 17, <i>p</i> = 0.011), Ang-2 (838 (473-1241) vs. 597 (274-1005), <i>p</i> = 0.018), and VEGF (72.2 (28-201.8) vs. 48.4 (17.4-110.1), <i>p</i> = 0.025) but reduced levels of AIx (21.7 ± 13.8 vs. 34 ± 12.9, <i>p</i> < 0.001) and Ang-1 (33.1 (24.7-42.1) vs. 41.1 (30-57.3), <i>p</i> = 0.01). In all study participants, compared to those in the lower tertile, participants in the upper tertile of Ang-2 had increased odds of PWV (2.01 (1.17-3.84), <i>p</i> = 0.004), aortic systolic BP (1.24 (1.04-1.97), <i>p</i> = 0.011), and aortic pulse BP (1.19 (1.04-1.82), <i>p</i> = 0.041) but reduced odds of AIx (0.84 (0.71-0.96), <i>p</i> = 0.014) in multivariable-adjusted models.</p><p><strong>Conclusion: </strong>In our study population, increased circulating Ang-2 was associated with increased levels of aortic stiffness parameters.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2023 ","pages":"3155982"},"PeriodicalIF":1.3,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49690485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aerobic Exercise versus Electronic Cigarette in Vascular Aging Process: First Histological Insight. 有氧运动与电子烟在血管老化过程中的作用:第一次组织学观察。
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-01-01 DOI: 10.1155/2023/8874599
Vito A Damay, Setiawan, Ronny Lesmana, Muhammad Rizki Akbar, Antonia Anna Lukito, Vita M Tarawan, Januar W Martha, J Nugroho, Sony Sugiharto

Smoking is related to vascular aging. However, the hazardous effect of e-cigarette is often debatable, with limited studies available. In contrast, moderate-intensity aerobic exercise is well known to decrease aortic stiffness. We provide novel research to determine the effect of e-cigarette and aerobic moderate-intensity exercise on the aortic structure of Wistar rats. A total of 26 male Wistar rats (Rattus norvegicus) 8 weeks aged, 200-250 g b.w., were randomly divided into 4 groups, namely, K0 (normal rats), K1 (rats were given moderate-intensity aerobic exercise by animal treadmill 20 m/30 min), K2 (rats were given e-cigarette with 6 mg nicotine, 40% propylene glycol, and 60% vegetable glycerine 30 min for 5 days/week), and K3 (rats were given e-cigarette and moderate-intensity aerobic exercise). After exposure for 6 weeks, all animals were sacrificed to isolate the aorta for histopathological analysis with hematoxylin-eosin stain to evaluate the elastic fiber layer and intimal-medial thickness. The Verhoeff-Van Gieson staining was done for quantification elastic lamina fragmentation. Our study found that the e-cigarette group had the highest elastic lamina fragmentation among groups (8.14 ± 2.85). The exercise only group showed the lowest elastic lamina fragmentation (2.50 ± 1.87). Fragmentation in the e-cigarette and exercise group was higher than in the exercise only group (5.83 ± 0.753 vs. 2.50 ± 1.87, p = 0.002). There is a significant difference of NO serum between four groups. The result of post hoc analysis using LSD showed that there is a significant difference of NO serum between K0 and K2, K0 and K3, K1 and K2, and K1 and K3. Therefore, our research demonstrated that the most injury of aorta elastic lamina was in the group that was exposed to e-cigarette that leads to vascular aging while exercise is not yet proven to reverse this effect.

吸烟与血管老化有关。然而,电子烟的有害影响往往是有争议的,可用的研究有限。相反,中等强度的有氧运动可以减少主动脉僵硬。我们提供了新的研究来确定电子烟和有氧中等强度运动对Wistar大鼠主动脉结构的影响。选取雄性褐家鼠(Rattus norvegicus) 26只,8周龄,200-250 g b.w.,随机分为4组,K0组(正常大鼠),K1组(在动物跑步机上进行20 m/30 min的中等强度有氧运动),K2组(给予尼古丁6 mg、40%丙二醇和60%植物甘油30 min的电子烟,连续5天/周),K3组(给予电子烟和中等强度有氧运动)。暴露6周后处死分离主动脉,用苏木精-伊红染色法进行组织病理学分析,评估弹性纤维层和内膜-内侧厚度。verhoefff - van Gieson染色定量测定弹性板断裂。我们的研究发现,电子烟组的弹性层裂率最高(8.14±2.85)。运动组弹性椎板碎裂率最低(2.50±1.87)。电子烟和运动组的碎片化程度高于运动组(5.83±0.753 vs. 2.50±1.87,p = 0.002)。四组间血清NO含量差异有统计学意义。LSD事后分析结果显示,血清NO在K0与K2、K0与K3、K1与K2、K1与K3之间存在显著差异。因此,我们的研究表明,主动脉弹性板损伤最严重的是电子烟暴露组,导致血管老化,而运动尚未被证明可以逆转这种影响。
{"title":"Aerobic Exercise versus Electronic Cigarette in Vascular Aging Process: First Histological Insight.","authors":"Vito A Damay,&nbsp;Setiawan,&nbsp;Ronny Lesmana,&nbsp;Muhammad Rizki Akbar,&nbsp;Antonia Anna Lukito,&nbsp;Vita M Tarawan,&nbsp;Januar W Martha,&nbsp;J Nugroho,&nbsp;Sony Sugiharto","doi":"10.1155/2023/8874599","DOIUrl":"https://doi.org/10.1155/2023/8874599","url":null,"abstract":"<p><p>Smoking is related to vascular aging. However, the hazardous effect of e-cigarette is often debatable, with limited studies available. In contrast, moderate-intensity aerobic exercise is well known to decrease aortic stiffness. We provide novel research to determine the effect of e-cigarette and aerobic moderate-intensity exercise on the aortic structure of Wistar rats. A total of 26 male Wistar rats (Rattus norvegicus) 8 weeks aged, 200-250 g b.w., were randomly divided into 4 groups, namely, K0 (normal rats), K1 (rats were given moderate-intensity aerobic exercise by animal treadmill 20 m/30 min), K2 (rats were given e-cigarette with 6 mg nicotine, 40% propylene glycol, and 60% vegetable glycerine 30 min for 5 days/week), and K3 (rats were given e-cigarette and moderate-intensity aerobic exercise). After exposure for 6 weeks, all animals were sacrificed to isolate the aorta for histopathological analysis with hematoxylin-eosin stain to evaluate the elastic fiber layer and intimal-medial thickness. The Verhoeff-Van Gieson staining was done for quantification elastic lamina fragmentation. Our study found that the e-cigarette group had the highest elastic lamina fragmentation among groups (8.14 ± 2.85). The exercise only group showed the lowest elastic lamina fragmentation (2.50 ± 1.87). Fragmentation in the e-cigarette and exercise group was higher than in the exercise only group (5.83 ± 0.753 vs. 2.50 ± 1.87, <i>p</i> = 0.002). There is a significant difference of NO serum between four groups. The result of post hoc analysis using LSD showed that there is a significant difference of NO serum between K0 and K2, K0 and K3, K1 and K2, and K1 and K3. Therefore, our research demonstrated that the most injury of aorta elastic lamina was in the group that was exposed to e-cigarette that leads to vascular aging while exercise is not yet proven to reverse this effect.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2023 ","pages":"8874599"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9935870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electronic Cigarette and Atherosclerosis: A Comprehensive Literature Review of Latest Evidences. 电子烟与动脉粥样硬化:最新证据的综合文献综述。
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-08-31 eCollection Date: 2022-01-01 DOI: 10.1155/2022/4136811
Vito Anggarino Damay, Setiawan, Ronny Lesmana, M Rizki Akbar, Antonia Anna Lukito, Vita M Tarawan, Januar W Martha, J Nugroho

Coronary artery diseases (CAD), also known as coronary heart disease (CHD), are the world's leading cause of death. The basis of coronary artery disease is the narrowing of the heart coronary artery lumen due to atherosclerosis. The use of electronic cigarettes has increased significantly over the years. However, harmful effects of electronic cigarettes are still not firm. The aim of this article is to review the impact of electronic cigarette and its role in the pathogenesis of atherosclerosis from recent studies. The results showed that several chemical compounds, such as nicotine, propylene glycol, particulate matters, heavy metals, and flavorings, in electronic cigarette induce atherosclerosis with each molecular mechanism that lead to atherosclerosis progression by formation of ROS, endothelial dysfunction, and inflammation. Further research is still needed to determine the exact mechanism and provide more clinical evidence.

冠状动脉疾病(CAD),也被称为冠心病(CHD),是世界上主要的死亡原因。冠状动脉疾病的基础是由于动脉粥样硬化引起的心脏冠状动脉管腔狭窄。近年来,电子烟的使用显著增加。然而,电子烟的有害影响仍然不确定。本文就电子烟的影响及其在动脉粥样硬化发病机制中的作用进行综述。结果表明,电子烟中的几种化合物,如尼古丁、丙二醇、颗粒物、重金属和调味剂,可诱导动脉粥样硬化,每种分子机制通过ROS的形成、内皮功能障碍和炎症导致动脉粥样硬化进展。还需要进一步的研究来确定确切的机制并提供更多的临床证据。
{"title":"Electronic Cigarette and Atherosclerosis: A Comprehensive Literature Review of Latest Evidences.","authors":"Vito Anggarino Damay,&nbsp;Setiawan,&nbsp;Ronny Lesmana,&nbsp;M Rizki Akbar,&nbsp;Antonia Anna Lukito,&nbsp;Vita M Tarawan,&nbsp;Januar W Martha,&nbsp;J Nugroho","doi":"10.1155/2022/4136811","DOIUrl":"https://doi.org/10.1155/2022/4136811","url":null,"abstract":"<p><p>Coronary artery diseases (CAD), also known as coronary heart disease (CHD), are the world's leading cause of death. The basis of coronary artery disease is the narrowing of the heart coronary artery lumen due to atherosclerosis. The use of electronic cigarettes has increased significantly over the years. However, harmful effects of electronic cigarettes are still not firm. The aim of this article is to review the impact of electronic cigarette and its role in the pathogenesis of atherosclerosis from recent studies. The results showed that several chemical compounds, such as nicotine, propylene glycol, particulate matters, heavy metals, and flavorings, in electronic cigarette induce atherosclerosis with each molecular mechanism that lead to atherosclerosis progression by formation of ROS, endothelial dysfunction, and inflammation. Further research is still needed to determine the exact mechanism and provide more clinical evidence.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2022 ","pages":"4136811"},"PeriodicalIF":1.3,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33461494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Potential Reduction in Adverse Events and Cost with Novel Anticoagulants among Patients with Acute Limb Ischemia 新型抗凝剂可能降低急性肢体缺血患者的不良事件和费用
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-06-07 DOI: 10.1155/2022/3786815
S. Freeman, Piper C. M. Williams, A. Barón, M. Plomondon, Stephen W. Waldo
Background Acute limb ischemia (ALI) is associated with significant morbidity and mortality. Novel anticoagulants reduce adverse events among patients with peripheral artery disease, though the potential effect of these therapies is unclear in patients with ALI. The present study thus sought to evaluate the potential clinical benefit of universal application of novel anticoagulants to a high-risk population of patients with ALI. Methods In this retrospective cohort study, we identified patients diagnosed with ALI in the Veterans Affairs Healthcare System between 2015 and 2016. We then calculated the incidence of adverse cardiovascular events (death/stroke/myocardial infarction/amputation/repeat intervention) as if they were treated with rivaroxaban using published data. Further, we calculated the cost to treat a Veteran diagnosed with one of these outcomes, and the potential savings had patients been universally treated with novel anticoagulants. Results We identified 286 patients that presented with lower extremity ALI and were not treated with anticoagulation. Potential treatment of these patients with rivaroxaban resulted in significantly fewer adverse events, with an 11.9% reduction in cases at 21 months (95% CI: 5.5-17.8%) and a 13.4% reduction in cases at 47 months (95% CI: 5.6-20.5%). This corresponded to significant decreases in healthcare spending for patients with ALI who were treated with rivaroxaban. Conclusions Among patients with ALI, treatment with rivaroxaban could result in a significant reduction in adverse cardiovascular events. The reduction in events would in turn lead to significant decreases in healthcare spending for this population.
背景:急性肢体缺血(ALI)与显著的发病率和死亡率相关。新型抗凝剂可减少外周动脉疾病患者的不良事件,尽管这些疗法对ALI患者的潜在影响尚不清楚。因此,本研究旨在评估在ALI高危人群中普遍应用新型抗凝剂的潜在临床益处。方法在这项回顾性队列研究中,我们确定了2015年至2016年在退伍军人事务医疗保健系统中诊断为ALI的患者。然后,我们计算不良心血管事件(死亡/中风/心肌梗死/截肢/重复干预)的发生率,就像使用利伐沙班治疗一样。此外,我们计算了治疗被诊断为这些结果之一的退伍军人的费用,以及如果患者普遍使用新型抗凝剂治疗,可能节省的费用。结果286例下肢ALI患者未接受抗凝治疗。利伐沙班对这些患者的潜在治疗导致不良事件显著减少,21个月时病例减少11.9% (95% CI: 5.5-17.8%), 47个月时病例减少13.4% (95% CI: 5.6-20.5%)。这与接受利伐沙班治疗的ALI患者的医疗支出显著降低相对应。结论:在ALI患者中,利伐沙班治疗可显著减少不良心血管事件。事件的减少反过来又会导致这一人群的医疗支出大幅减少。
{"title":"Potential Reduction in Adverse Events and Cost with Novel Anticoagulants among Patients with Acute Limb Ischemia","authors":"S. Freeman, Piper C. M. Williams, A. Barón, M. Plomondon, Stephen W. Waldo","doi":"10.1155/2022/3786815","DOIUrl":"https://doi.org/10.1155/2022/3786815","url":null,"abstract":"Background Acute limb ischemia (ALI) is associated with significant morbidity and mortality. Novel anticoagulants reduce adverse events among patients with peripheral artery disease, though the potential effect of these therapies is unclear in patients with ALI. The present study thus sought to evaluate the potential clinical benefit of universal application of novel anticoagulants to a high-risk population of patients with ALI. Methods In this retrospective cohort study, we identified patients diagnosed with ALI in the Veterans Affairs Healthcare System between 2015 and 2016. We then calculated the incidence of adverse cardiovascular events (death/stroke/myocardial infarction/amputation/repeat intervention) as if they were treated with rivaroxaban using published data. Further, we calculated the cost to treat a Veteran diagnosed with one of these outcomes, and the potential savings had patients been universally treated with novel anticoagulants. Results We identified 286 patients that presented with lower extremity ALI and were not treated with anticoagulation. Potential treatment of these patients with rivaroxaban resulted in significantly fewer adverse events, with an 11.9% reduction in cases at 21 months (95% CI: 5.5-17.8%) and a 13.4% reduction in cases at 47 months (95% CI: 5.6-20.5%). This corresponded to significant decreases in healthcare spending for patients with ALI who were treated with rivaroxaban. Conclusions Among patients with ALI, treatment with rivaroxaban could result in a significant reduction in adverse cardiovascular events. The reduction in events would in turn lead to significant decreases in healthcare spending for this population.","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2022 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48725112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study 中东地区房颤患者一年的临床结果:约旦房颤(JoFib)研究
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-04-13 DOI: 10.1155/2022/4240999
A. Hammoudeh, Yousef Khader, R. Tabbalat, Y. Badaineh, N. Kadri, H. Shawer, E. Al-Mousa, R. Ibdah, Batool A. Shawer, I. Alhaddad
Background Prevention of stroke and systemic embolism (SE) prevention in patients with atrial fibrillation (AF) has radically changed in recent years. Data on contemporary utilization of oral anticoagulants (OACs) and cardiovascular outcome in Middle Eastern patients with AF are needed. Methods The Jordan atrial fibrillation (JoFib) study enrolled consecutive patients with AF in Jordan from May 2019 through October 2020 and were followed up for one year after enrollment. Results Overall, 2020 patients were enrolled. The mean age was 67.9 + 13.0 years. Nonvalvular (NVAF) was diagnosed in 1849 (91.5%) patients. OACs were used in 85.7% of high-risk patients with NVAF (CHA2DS2-VASc score>3 in women, and>2 in men), including direct OACs (DOACs) in 64.1% and vitamin K antagonists (VKA) in 35.9%. Adherence rate to the use of the same OAC agent was 90.6% of patients. One-year cardiovascular (CV) mortality was 7.8%, stroke/SE was 4.5%, and major bleeding events were 2.6%. Independent predictors for all-cause mortality in patients with NVAF were age>75 years, heart failure, major bleeding event, type 2 diabetes mellitus, study enrollment as an in-patient, and coronary heart disease. The use of OACs was associated with lower all-cause mortality. The strongest independent predictors for stroke/SE were high-risk CHA2DS2-VASc score and prior history of stroke. Conclusions This study of Middle Eastern AF patients has reported high adherence to OACs. The use of OACs was associated with a lower risk for all-cause mortality. One-year rates of stroke and major bleeding events were comparable to those reported from other regions in the world.
背景:近年来,房颤(AF)患者的卒中预防和系统性栓塞(SE)预防发生了根本性的变化。需要有关中东房颤患者口服抗凝剂(OACs)的当代使用情况和心血管预后的数据。方法约旦心房颤动(JoFib)研究于2019年5月至2020年10月在约旦招募了连续的AF患者,并在入组后随访一年。结果共纳入2020例患者。平均年龄67.9 + 13.0岁。1849例(91.5%)患者被诊断为非瓣膜性房颤。85.7%的非瓣膜性房颤高危患者(女性CHA2DS2-VASc评分为bbb3,男性为bbb2)使用了OACs,其中直接OACs (DOACs)占64.1%,维生素K拮抗剂(VKA)占35.9%。使用同一种OAC药物的依从率为90.6%。一年心血管(CV)死亡率为7.8%,卒中/SE为4.5%,大出血事件为2.6%。非瓣膜性房颤患者全因死亡率的独立预测因子为年龄0 ~ 75岁、心力衰竭、大出血事件、2型糖尿病、作为住院患者纳入研究和冠心病。使用OACs与较低的全因死亡率相关。卒中/SE最强的独立预测因子是高危CHA2DS2-VASc评分和既往卒中史。结论:这项中东房颤患者的研究报告了OACs的高依从性。OACs的使用与全因死亡风险降低相关。一年的中风和大出血事件发生率与世界其他地区的报告相当。
{"title":"One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study","authors":"A. Hammoudeh, Yousef Khader, R. Tabbalat, Y. Badaineh, N. Kadri, H. Shawer, E. Al-Mousa, R. Ibdah, Batool A. Shawer, I. Alhaddad","doi":"10.1155/2022/4240999","DOIUrl":"https://doi.org/10.1155/2022/4240999","url":null,"abstract":"Background Prevention of stroke and systemic embolism (SE) prevention in patients with atrial fibrillation (AF) has radically changed in recent years. Data on contemporary utilization of oral anticoagulants (OACs) and cardiovascular outcome in Middle Eastern patients with AF are needed. Methods The Jordan atrial fibrillation (JoFib) study enrolled consecutive patients with AF in Jordan from May 2019 through October 2020 and were followed up for one year after enrollment. Results Overall, 2020 patients were enrolled. The mean age was 67.9 + 13.0 years. Nonvalvular (NVAF) was diagnosed in 1849 (91.5%) patients. OACs were used in 85.7% of high-risk patients with NVAF (CHA2DS2-VASc score>3 in women, and>2 in men), including direct OACs (DOACs) in 64.1% and vitamin K antagonists (VKA) in 35.9%. Adherence rate to the use of the same OAC agent was 90.6% of patients. One-year cardiovascular (CV) mortality was 7.8%, stroke/SE was 4.5%, and major bleeding events were 2.6%. Independent predictors for all-cause mortality in patients with NVAF were age>75 years, heart failure, major bleeding event, type 2 diabetes mellitus, study enrollment as an in-patient, and coronary heart disease. The use of OACs was associated with lower all-cause mortality. The strongest independent predictors for stroke/SE were high-risk CHA2DS2-VASc score and prior history of stroke. Conclusions This study of Middle Eastern AF patients has reported high adherence to OACs. The use of OACs was associated with a lower risk for all-cause mortality. One-year rates of stroke and major bleeding events were comparable to those reported from other regions in the world.","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2022 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2022-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"64777590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
High Frequency of Microvascular Dysfunction in US Outpatient Clinics: A Sign of High Residual Risk? Data from 7,105 Patients. 美国门诊微血管功能障碍的高频率:高残留风险的标志?数据来自7105名患者。
IF 1.3 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-01-06 eCollection Date: 2022-01-01 DOI: 10.1155/2022/4224975
Morteza Naghavi, Stanley Kleis, Hirofumi Tanaka, Albert A Yen, Ruoyu Zhuang, Ahmed Gul, Yasamin Naghavi, Ralph Metcalfe

Previous studies have linked peripheral microvascular dysfunction measured by arterial tonometry to high residual risk in on-statin patients. Digital thermal monitoring (DTM) of microvascular function is a new and simplified technique based on fingertip temperature measurements that has been correlated with the burden of atherosclerosis and its risk factors. Here, we report analyses of DTM data from two large US registries: Registry-I (6,084 cases) and Registry-II (1,021 cases) across 49 US outpatient clinics. DTM tests were performed using a VENDYS device during a 5-minute arm-cuff reactive hyperemia. Fingertip temperature falls during cuff inflation and rebounds after deflation. Adjusted maximum temperature rebound was reported as vascular reactivity index (VRI). VRI distributions were similar in both registries, with mean ± SD of 1.58 ± 0.53 in Registry-I and 1.52 ± 0.43 in Registry-II. In the combined dataset, only 18% had optimal VRI (≥2.0) and 82% were either poor (<1.0) or intermediate (1.0-2.0). Women had slightly higher VRI than men (1.62 ± 0.56 vs. 1.54 ± 0.47, p < 0.001). VRI was inversely but mildly correlated with age (r = -0.19, p < 0.001). Suboptimal VRI was found in 72% of patients <50 years, 82% of 50-70 years, and 86% of ≥70 years. Blood pressure was not correlated with VRI. In this largest registry of peripheral microvascular function measurements, suboptimal scores were highly frequent among on-treatment patients, possibly suggesting a significant residual risk. Prospective studies are warranted to validate microvascular dysfunction as an indicator of residual risk.

先前的研究已经将动脉血压计测量的外周微血管功能障碍与服用他汀类药物患者的高残留风险联系起来。微血管功能数字热监测(DTM)是一种基于指尖温度测量的新型简化技术,与动脉粥样硬化负担及其危险因素相关。在这里,我们报告了来自美国两个大型登记处的DTM数据的分析:登记处- i(6084例)和登记处- ii(1021例),横跨49个美国门诊诊所。在5分钟的臂袖反应性充血期间,使用VENDYS设备进行DTM测试。袖口膨胀时指尖温度下降,收缩后又反弹。调整后的最高温度回弹作为血管反应性指数(VRI)。两个注册中心的VRI分布相似,注册中心i的平均±SD为1.58±0.53,注册中心ii的平均±SD为1.52±0.43。在合并的数据集中,只有18%的VRI达到最佳(≥2.0),82%的VRI较差(p < 0.001)。VRI与年龄呈负相关但轻度相关(r = -0.19, p < 0.001)。72%的患者VRI不理想
{"title":"High Frequency of Microvascular Dysfunction in US Outpatient Clinics: A Sign of High Residual Risk? Data from 7,105 Patients.","authors":"Morteza Naghavi,&nbsp;Stanley Kleis,&nbsp;Hirofumi Tanaka,&nbsp;Albert A Yen,&nbsp;Ruoyu Zhuang,&nbsp;Ahmed Gul,&nbsp;Yasamin Naghavi,&nbsp;Ralph Metcalfe","doi":"10.1155/2022/4224975","DOIUrl":"https://doi.org/10.1155/2022/4224975","url":null,"abstract":"<p><p>Previous studies have linked peripheral microvascular dysfunction measured by arterial tonometry to high residual risk in on-statin patients. Digital thermal monitoring (DTM) of microvascular function is a new and simplified technique based on fingertip temperature measurements that has been correlated with the burden of atherosclerosis and its risk factors. Here, we report analyses of DTM data from two large US registries: Registry-I (6,084 cases) and Registry-II (1,021 cases) across 49 US outpatient clinics. DTM tests were performed using a VENDYS device during a 5-minute arm-cuff reactive hyperemia. Fingertip temperature falls during cuff inflation and rebounds after deflation. Adjusted maximum temperature rebound was reported as vascular reactivity index (VRI). VRI distributions were similar in both registries, with mean ± SD of 1.58 ± 0.53 in Registry-I and 1.52 ± 0.43 in Registry-II. In the combined dataset, only 18% had optimal VRI (≥2.0) and 82% were either poor (<1.0) or intermediate (1.0-2.0). Women had slightly higher VRI than men (1.62 ± 0.56 vs. 1.54 ± 0.47, <i>p</i> < 0.001). VRI was inversely but mildly correlated with age (<i>r</i> = -0.19, <i>p</i> < 0.001). Suboptimal VRI was found in 72% of patients <50 years, 82% of 50-70 years, and 86% of ≥70 years. Blood pressure was not correlated with VRI. In this largest registry of peripheral microvascular function measurements, suboptimal scores were highly frequent among on-treatment patients, possibly suggesting a significant residual risk. Prospective studies are warranted to validate microvascular dysfunction as an indicator of residual risk.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2022 ","pages":"4224975"},"PeriodicalIF":1.3,"publicationDate":"2022-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758294/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39939543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Vascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1